Dr. Joao P. De Aquino, M.D.

Claim this profile

VA Healthcare System

Studies Chronic Persistent Surgical Pain
Studies Pain
4 reported clinical trials
4 drugs studied

Affiliated Hospitals

Image of trial facility.
VA Healthcare System
Image of trial facility.
Department Of Veterans Affairs Hospital

Clinical Trials Joao P. De Aquino, M.D. is currently running

Image of trial facility.

Dronabinol

for Pain Management in Opioid Users

Twenty male and female (ages 18-70) participants with OUD currently receiving methadone or buprenorphine will be enrolled. Prior to their daily methadone or buprenorphine dose and thus at trough plasma levels of opioid, participants will receive dronabinol (2.5 mg, 5mg) or placebo. Subsequently, all participants will undergo laboratory testing of opioid-related outcomes. Pain sensitivity will be measured using a technique called the (QST) quantitative sensory testing, which involves the administering heat or cold stimulation. A Short-Form McGill Pain Questionnaire (SF-MPQ) and a pain Visual Analog Scale (VAS). Attentional bias will be measured using a visual probe task. Negative affect will be measured using the Positive and Negative Affect Schedule (PANAS). Cognitive performance will be measured by a comprehensive cognitive battery. The order of study medication administration will be counterbalanced order to minimize carryover effects. On the initial screening day and at the end of medication treatment, blood will be drawn to determine serum cytokine levels. One week after the last study medication dose, a follow-up session will be conducted during which participants will undergo urine toxicology testing and a safety evaluation before final discharge from the study.
Recruiting0 awards Phase < 1
Image of trial facility.

THC

for Pain Relief in Older Adults

The overarching goal of this double-blind, placebo-controlled, crossover study is to characterize the pharmacokinetic (PK) and pharmacodynamic (PD) effects of the main analgesic and psychoactive constituent of cannabis, delta-9 tetrahydrocannabinol (THC), among older adults - the fastest growing population of cannabis consumers, and the most likely age cohort to use cannabinoids to relieve pain. This protocol includes two sub-studies, each randomizing 20 men and women aged 65 years or older to receive two administration routes of THC; oral administration and vaporized administration.
Recruiting0 awards Phase < 1

More about Joao P. De Aquino, M.D.

Clinical Trial Related6 years of experience running clinical trials · Led 4 trials as a Principal Investigator · 3 Active Clinical Trials
Treatments Joao P. De Aquino, M.D. has experience with
  • Dronabinol
  • Placebo
  • Cannabidiol
  • Purified THC In An Ethanolic Solution

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?
What does Joao P. De Aquino, M.D. specialize in?
Is Joao P. De Aquino, M.D. currently recruiting for clinical trials?
Are there any treatments that Joao P. De Aquino, M.D. has studied deeply?
What is the best way to schedule an appointment with Joao P. De Aquino, M.D.?
What is the office address of Joao P. De Aquino, M.D.?
Is there any support for travel costs?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security